EMEA-001557-PIP01-13-M06 - paediatric investigation plan

Roxadustat

Key facts

• Active Substance:
  Roxadustat
• Therapeutic area:
  Haematology-Hemostaseology
• Decision number:
  P/0400/2022
• PIP number:
  EMEA-001557-PIP01-13-M06
• Pharmaceutical form(s):
  Film-coated tablet
• Condition(s) / indication(s):
  Treatment of anaemia due to chronic disorders
• Route(s) of administration:
  • Oral use
  • Gastric use
• Contact for public enquiries:

  Astellas Pharma Europe B.V.

  E-mail: [e-mail]; Tel: [phone]

• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  09/09/2022

Decision

P/0400/2022 : EMA decision of 9 September 2022 on the acceptance of a modification of an agreed paediatric investigation plan for roxadustat (Evrenzo), (EMEA-001557-PIP01-13-M06)

Reference Number: EMA/709114/2022